The government said it will start inoculating high-risk groups with updated booster shots that can defend against the Omicron variants from Oct. 11Health officials explained that it will use Moderna's bivalent vaccine for the inoculation.Those aged 60 and over, with weakened immunity, and patients i
HiPex (Hospital Innovation and Patient Experience Conference), which brought up topics like “patient experience” and “service design” for the first time in Korea in 2014, will return this year as “HiPex 2022.”The conference, which breathed fresh air from 2014 to 2019, has since been suspended due to
A joint research team from Korea Advanced Institute of Science and Technology (KAIST) said on Wednesday they developed a bio-friendly adhesive by mixing tannic acid with bio-compatible polymers to improve existing hair transplant methods.Tannic acid is a type of polyphenol found in fruit shells, nut
Shaperon said it would strive to be a leader in autoimmune disease treatment by going public on the Kosdaq market in October.Shaperon started as a Seoul National University venture in 2008 based on the world's first inflammation initiation theory, DAMP (Damage Associated Molecular Patterns), discove
HLB’s U.S. affiliate, Verismo Therapeutics and GC Cell’s U.S. affiliate, Artiva Biotherapeutics announced this week that they obtained phase 1 IND approval from the FDA for their respective next-generation chimeric antigen receptor (CAR-T) treatments.Accordingly, Verismo will evaluate the safety, re
Myongji Hospital said that it has partnered with Why Dots to co-develop the latter's dementia specialized robot, PIO, and produce cognitive intervention programs.PIO is a robot parrot that stimulates attachment and emotion in dementia patients through the process of taking care of the robot. Accordi
The Organization for Economic Cooperation and Development has advised Korea to increase the number of students admitted to medical schools and introduce a pay-for-performance system.With the current healthcare system, the country cannot meet populating aging and medical needs for chronic diseases, i
The U.S. Food and Drug Administration (FDA) on Tuesday raised concerns over the safety and efficacy of poziotinib, a non-small cell lung cancer (NSCLC) licensed out by Hanmi Pharmaceutical to Spectrum Pharmaceuticals. Poziotinib aims to treat NSCLC with locally advanced and metastatic HER2 Exon 20 i
Coincidentally, Korea, a country with declining birth rates, also happens to be the only country possessing such a unique culture of flourishing post-partum care centers. What could be the underlying reason for this strange phenomenon?In an interview with Korea Biomedical Review, Lee Eun-ha, mother
The quarantine authorities said that they would consider further lifting or easing quarantine policies, including the requirement for all overseas entrants to undergo a polymerase chain reaction (PCR) test within one day after entering Korea."As the current epidemic is slowing down, we are preparing
The bio-medical industry, which was the largest investment destination for venture capital (VC) companies from 2018 to 2020, slumped to third place in the first half of this year.According to a report by the Biotech Policy Research Center, new VC investment in the bio-medical industry was 675.8 bill
A study has shown that the death risk of people with non-alcoholic fatty liver is 67 percent higher than ordinary people. It also found that the death risk was exceptionally high if the patients were underweight.A joint research team – led by Professor Yu Soo-jong of the Seoul National University Ho
Enhertu, a new breast and stomach cancer treatment, has won domestic approval.The Ministry of Food and Drug Safety said Monday that it would approve Enhertu Inj. 100 mg (trastuzumab deruxtecan), a breast and stomach cancer treatment, which will be marketed by Daiichi Sankyo Korea.The domestic approv
The Yonsei University Health System (YUHS) will introduce the heavy ion therapy, called a dream cancer treatment device, around next March and use it for treating cancer patients. YUHS will be the 16th institution worldwide to use the therapy, and Korea will be the only country that runs three ion a
The Asian Oceanian Congress of Radiology and Korean Congress of Radiology 2022 (AOCR 2022 & KCR 2022) kicked off its five-day run in COEX, southern Seoul, on Tuesday.KCR is one of the leading radiology conferences in Asia hosted by the Korean Society of Radiology (KSR). This year is also the first t
Panagene said on Monday it signed a contract with Yuhan Corp. to jointly develop the original companion diagnostic (CDx), called PANAMutyper R EGFR, for Yuhan’s lung cancer drug Leclaza (lazertinib).According to the FDA, a CDx is a medical device which provides information that is essential for the
Celltrion said on Tuesday that it won a patent invalidation lawsuit against Roche (Genentech) in Taiwan for the Rheumatoid Arthritis (RA) indication of Truxima, a biosimilar of the original drug Rituxan (ingredient name: rituximab).Celltrion had previously invalidated the related patent in Korea in
SillaJen said it inked a deal with Basilea Pharmaceutica, a Switzerland-based biopharmaceutical company, to license in the latter's BAL0891, an anticancer drug candidate.Under the agreement, Basilea will receive an upfront payment of $14 million and can receive up to $335 million for milestones acco
Drugmakers are gearing up to race in the development of a denosumab biosimilar to treat various bone diseases. Sandoz, a subsidiary of Novartis handling off-patent medicines, said on Monday that it confirmed positive results from a study of a proposed biosimilar denosumab (original brands: Prolia, X
The country added 19,407 new Covid-19 infections, including 289 cases from abroad, bringing the total caseload to 24,413,873, according to the Korea Disease Control and Prevention Agency (KDCA). The figure is the lowest since July 11, when the country reported 12,672 cases.The nation also reported 3